Page last updated: 2024-08-24

atorvastatin and Uremia

atorvastatin has been researched along with Uremia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berg, AH; Drechsler, C; Hod, T; Kalim, S; Karumanchi, SA; Suntharalingam, P; Thadhani, RI; Wanner, C; Wenger, JB	1
Ayalon, R; Chernichovski, T; Chernin, G; Levo, Y; Litvak, A; Reshef, R; Schwartz, D; Schwartz, IF; Weinstein, T	1
Bajo, MA; del Peso, G; Díez, JJ; Estrada, PN; Fernández-Reyes, MJ; Grande, C; Iglesias, P; Sánchez Hernández, R; Selgas, R	1
Hufnagel, G; Kossari, N; Michel, C; Mignon, F; Queffeulou, G; Vrtovsnik, F	1

Trials

2 trial(s) available for atorvastatin and Uremia

Article	Year
Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease. Kidney international, 2015, Volume: 87, Issue:6 Topics: Aged; Atorvastatin; Atrial Fibrillation; Cause of Death; Cholesterol; Comorbidity; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Renal Dialysis; Risk Factors; Serum Albumin; Survival Rate; Troponin T; Uremia	2015
Effects of atorvastatin on dyslipidaemia in uraemic patients on peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:5 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Peritoneal Dialysis; Prospective Studies; Pyrroles; Triglycerides; Uremia	2000

Article

Year

Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.

Kidney international, 2015, Volume: 87, Issue:6

Topics: Aged; Atorvastatin; Atrial Fibrillation; Cause of Death; Cholesterol; Comorbidity; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Renal Dialysis; Risk Factors; Serum Albumin; Survival Rate; Troponin T; Uremia

2015

Effects of atorvastatin on dyslipidaemia in uraemic patients on peritoneal dialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:5

Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Peritoneal Dialysis; Prospective Studies; Pyrroles; Triglycerides; Uremia

2000

Other Studies

2 other study(ies) available for atorvastatin and Uremia

Article	Year
Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats. Kidney international, 2006, Volume: 69, Issue:2 Topics: Animals; Aorta; Arginine; Atorvastatin; Biological Transport; Cationic Amino Acid Transporter 1; Cationic Amino Acid Transporter 2; Creatinine; Gene Expression Regulation; Heptanoic Acids; In Vitro Techniques; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nitric Oxide; Pyrroles; Rats; Rats, Wistar; Uremia	2006
[Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2006, Volume: 26, Issue:6 Topics: Adiponectin; Animals; Atorvastatin; Cardiovascular Diseases; Coronary Restenosis; Disease Models, Animal; Heptanoic Acids; Humans; Insulin Resistance; Kidney Failure, Chronic; Peritoneal Dialysis; PPAR gamma; Prospective Studies; Pyrroles; Rats; Renal Dialysis; Risk Factors; Thiazolidinediones; Uremia	2006

Article

Year

Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats.

Kidney international, 2006, Volume: 69, Issue:2

Topics: Animals; Aorta; Arginine; Atorvastatin; Biological Transport; Cationic Amino Acid Transporter 1; Cationic Amino Acid Transporter 2; Creatinine; Gene Expression Regulation; Heptanoic Acids; In Vitro Techniques; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nitric Oxide; Pyrroles; Rats; Rats, Wistar; Uremia

2006

[Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2006, Volume: 26, Issue:6

Topics: Adiponectin; Animals; Atorvastatin; Cardiovascular Diseases; Coronary Restenosis; Disease Models, Animal; Heptanoic Acids; Humans; Insulin Resistance; Kidney Failure, Chronic; Peritoneal Dialysis; PPAR gamma; Prospective Studies; Pyrroles; Rats; Renal Dialysis; Risk Factors; Thiazolidinediones; Uremia

2006